These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 28870897)

  • 1. Phosphoproteomic Analysis Identifies Signaling Pathways Regulated by Curcumin in Human Colon Cancer Cells.
    Sato T; Higuchi Y; Shibagaki Y; Hattori S
    Anticancer Res; 2017 Sep; 37(9):4789-4798. PubMed ID: 28870897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Ethanol Extract of Hawaiian Turmeric: Extensive In Vitro Anticancer Activity Against Human Colon Cancer Cells.
    Dimas K; Tsimplouli C; Houchen C; Pantazis P; Sakellaridis N; Tsangaris GT; Anastasiadou E; Ramanujam RP
    Altern Ther Health Med; 2015; 21 Suppl 2():46-54. PubMed ID: 26308760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1.
    Chen A; Xu J; Johnson AC
    Oncogene; 2006 Jan; 25(2):278-87. PubMed ID: 16170359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Curcumin Analogue, MS13 (1,5-Bis(4-hydroxy-3- methoxyphenyl)-1,4-pentadiene-3-one), Inhibits Cell Proliferation and Induces Apoptosis in Primary and Metastatic Human Colon Cancer Cells.
    Ismail NI; Othman I; Abas F; H Lajis N; Naidu R
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32825505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells.
    Beevers CS; Li F; Liu L; Huang S
    Int J Cancer; 2006 Aug; 119(4):757-64. PubMed ID: 16550606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin Induces Autophagy via Inhibition of Yes-Associated Protein (YAP) in Human Colon Cancer Cells.
    Zhu J; Zhao B; Xiong P; Wang C; Zhang J; Tian X; Huang Y
    Med Sci Monit; 2018 Oct; 24():7035-7042. PubMed ID: 30281585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of curcumin on gastric cancer cells: a proteomic study of molecular targets.
    Cai XZ; Huang WY; Qiao Y; Du SY; Chen Y; Chen D; Yu S; Che RC; Liu N; Jiang Y
    Phytomedicine; 2013 Apr; 20(6):495-505. PubMed ID: 23351961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcuminoids-cellular uptake by human primary colon cancer cells as quantitated by a sensitive HPLC assay and its relation with the inhibition of proliferation and apoptosis.
    Hsu YC; Weng HC; Lin S; Chien YW
    J Agric Food Chem; 2007 Oct; 55(20):8213-22. PubMed ID: 17760412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin inhibits growth potential by G1 cell cycle arrest and induces apoptosis in p53-mutated COLO 320DM human colon adenocarcinoma cells.
    Dasiram JD; Ganesan R; Kannan J; Kotteeswaran V; Sivalingam N
    Biomed Pharmacother; 2017 Feb; 86():373-380. PubMed ID: 28011386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer.
    Mariadason JM; Corner GA; Augenlicht LH
    Cancer Res; 2000 Aug; 60(16):4561-72. PubMed ID: 10969808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ Proteomic Profiling of Curcumin Targets in HCT116 Colon Cancer Cell Line.
    Wang J; Zhang J; Zhang CJ; Wong YK; Lim TK; Hua ZC; Liu B; Tannenbaum SR; Shen HM; Lin Q
    Sci Rep; 2016 Feb; 6():22146. PubMed ID: 26915414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin mediates anticancer effects by modulating multiple cell signaling pathways.
    Kunnumakkara AB; Bordoloi D; Harsha C; Banik K; Gupta SC; Aggarwal BB
    Clin Sci (Lond); 2017 Aug; 131(15):1781-1799. PubMed ID: 28679846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR.
    Chen A; Xu J
    Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G447-56. PubMed ID: 15486348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin and emodin down-regulate TGF-β signaling pathway in human cervical cancer cells.
    Thacker PC; Karunagaran D
    PLoS One; 2015; 10(3):e0120045. PubMed ID: 25786122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-silico and in-vitro anti-cancer potential of a curcumin analogue (1E, 6E)-1, 7-di (1H-indol-3-yl) hepta-1, 6-diene-3, 5-dione.
    Sufi SA; Adigopula LN; Syed SB; Mukherjee V; Coumar MS; Rao HS; Rajagopalan R
    Biomed Pharmacother; 2017 Jan; 85():389-398. PubMed ID: 27889234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Cancer Mechanisms of Diarylpentanoid MS17 (1,5-Bis(2-hydroxyphenyl)-1,4-pentadiene-3-one) in Human Colon Cancer Cells: A Proteomics Approach.
    Hon KW; Zainal Abidin SA; Abas F; Othman I; Naidu R
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin causes superoxide anion production and p53-independent apoptosis in human colon cancer cells.
    Watson JL; Hill R; Yaffe PB; Greenshields A; Walsh M; Lee PW; Giacomantonio CA; Hoskin DW
    Cancer Lett; 2010 Nov; 297(1):1-8. PubMed ID: 20472336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of differentially expressed proteins in curcumin-treated prostate cancer cell lines.
    Teiten MH; Gaigneaux A; Chateauvieux S; Billing AM; Planchon S; Fack F; Renaut J; Mack F; Muller CP; Dicato M; Diederich M
    OMICS; 2012 Jun; 16(6):289-300. PubMed ID: 22475723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular targets of curcumin for cancer therapy: an updated review.
    Kasi PD; Tamilselvam R; Skalicka-Woźniak K; Nabavi SF; Daglia M; Bishayee A; Pazoki-Toroudi H; Nabavi SM
    Tumour Biol; 2016 Oct; 37(10):13017-13028. PubMed ID: 27468716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex.
    Plummer SM; Holloway KA; Manson MM; Munks RJ; Kaptein A; Farrow S; Howells L
    Oncogene; 1999 Oct; 18(44):6013-20. PubMed ID: 10557090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.